| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophysical Journal 70: 2696-2703 (1996)
© 1996 the Biophysical Society
Department of Physiology and Biophysics, University of Alabama at Birmingham 35294, USA.
ABSTRACT
Cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial Cl- channel that is regulated by protein kinase A and cytosolic nucleotides. Previously, Sheppard and Welsh reported that the sulfonylureas glibenclamide and tolbutamide reduced CFTR whole cell currents. The aim of this study was to quantify the effects of tolbutamide on CFTR gating in excised membrane patches containing multiple channels. We chose tolbutamide because weak (i.e., fast-type) open channel blockers introduce brief events into multichannel recordings that can be readily quantified by current fluctuation analysis. Inspection of current records revealed that the addition of tolbutamide reduced the apparent single-channel current amplitude and increased the open-channel noise, as expected for a fast-type open channel blocker. The apparent decrease in unitary current amplitude provides a measure of open probability within a burst (P0 Burst), and the resulting concentration-response relationship was described by a simple Michaelis-Menten inhibition function. The concentration of tolbutamide causing a 50% reduction of Po Burst (540 +/- 20 microM) was similar to the concentration producing a 50% inhibition of short-circuit current across T84 colonic epithelial cell monolayers (400 +/- 20 microM). Changes in CFTR gating were then quantified by analyzing current fluctuations. Tolbutamide caused a high-frequency Lorentzian (corner frequency, fc > 300 Hz) to appear in the power density spectrum. The fc of this Lorentzian component increased as a linear function of tolbutamide concentration, as expected for a pseudo-first-order open-blocked mechanism and yielded estimates of the on rate (koff = 2.8 +/- 0.3 microM-1 s-1), the off rate (kon = 1210 +/- 225 s-1), and the dissociation constant (KD = 430 +/- 80 microM). Based on these observations, we propose that there is a bimolecular interaction between tolbutamide and CFTR, causing open channel blockade.
This article has been cited by other articles:
 |
|
 |
|
  T.-Y. Chen and T.-C. Hwang CLC-0 and CFTR: Chloride Channels Evolved From Transporters Physiol Rev, April 1, 2008; 88(2): 351 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Venglarik, Z. Gao, and X. Lu Evolutionary Conservation of Drosophila Polycystin-2 as a Calcium-Activated Cation Channel J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1168 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chen, Y. Dong, and J. M. Simard Functional Coupling between Sulfonylurea Receptor Type 1 and a Nonselective Cation Channel in Reactive Astrocytes from Adult Rat Brain J. Neurosci., September 17, 2003; 23(24): 8568 - 8577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.D. Gong, P. Linsdell, K.H. Cheung, G.P.H. Leung, and P.Y.D. Wong Indazole Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channels in Rat Epididymal Epithelial Cells Biol Reprod, December 1, 2002; 67(6): 1888 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Cai and D. N. Sheppard Phloxine B Interacts with the Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Sites to Modulate Channel Activity J. Biol. Chem., May 24, 2002; 277(22): 19546 - 19553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gao, J. R. Yankaskas, C. M. Fuller, E. J. Sorscher, S. Matalon, H. J. Forman, and C. J. Venglarik Chlorzoxazone or 1-EBIO increases Na+ absorption across cystic fibrosis airway epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1123 - L1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. O'Donnell, R. L. Sedlacek, A. K. Singh, and B. D. Schultz Inhibition of enterotoxin-induced porcine colonic secretion by diarylsulfonylureas in vitro Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1104 - G1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Singh, B. D. Schultz, J. A. Katzenellenbogen, E. M. Price, R. J. Bridges, and N. A. Bradbury Estrogen Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator-Mediated Chloride Secretion J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 195 - 204. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. McCarty Permeation through the CFTR chloride channel J. Exp. Biol., January 7, 2000; 203(13): 1947 - 1962. [Abstract] [PDF]
|
|
|
|
|
|
D. N. SHEPPARD and M. J. WELSH Structure and Function of the CFTR Chloride Channel Physiol Rev, January 1, 1999; 79(1): 23 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. DAWSON, S. S. SMITH, and M. K. MANSOURA CFTR: Mechanism of Anion Conduction Physiol Rev, January 1, 1999; 79(1): 47 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES Pharmacology of CFTR Chloride Channel Activity Physiol Rev, January 1, 1999; 79(1): 109 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, S. Oiki, T. Tsumura, T. Shimizu, and Y. Okada Glibenclamide blocks volume-sensitive Cl- channels by dual mechanisms Am J Physiol Cell Physiol, August 1, 1998; 275(2): C343 - C351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Walsh and C. Wang Arylaminobenzoate Block of the Cardiac Cyclic AMP-Dependent Chloride Current Mol. Pharmacol., March 1, 1998; 53(3): 539 - 546. [Abstract] [Full Text]
|
|
|
|
|
|
B. D. Schultz, A. Takahashi, C. Liu, R. A. Frizzell, and M. Howard FLAG epitope positioned in an external loop preserves normal biophysical properties of CFTR Am J Physiol Cell Physiol, December 1, 1997; 273(6): C2080 - C2089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yamazaki and J. R. Hume Inhibitory Effects of Glibenclamide on Cystic Fibrosis Transmembrane Regulator, Swelling-Activated, and Ca2+-Activated Cl- Channels in Mammalian Cardiac Myocytes Circ. Res., July 19, 1997; 81(1): 101 - 109. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
